Search Within
Document Type
111-77-3
Applied Filters:
Keyword:'111-77-3'
Showing 1-30 of 174 results for "111-77-3" within Technical Documents
The Effective Use of Protein Kinase Inhibitors
91 70 99 98 97 3 4 7
PDK1 104 115 92 36 70 99 85 86 89 87 88 76 81 110 105 98 84 85 69
PKBα 17 90 88 27 67 79 89 82 62
The Effective Use of Protein Kinase Inhibitors
91 70 99 98 97 3 4 7
PDK1 104 115 92 36 70 99 85 86 89 87 88 76 81 110 105 98 84 85 69
PKBα 17 90 88 27 67 79 89 82 62
MILLIPLEX®MAP Human Myokine Panel is an optimized quantitative immunoassay that simultaneously measures 15 novel muscle-secreted factors
Irisin FSTL1 OSM IL-6 FGF21 Musclin
1:4 dil 111 85 58 105 100 97 95 74 92 106 73 106 77 91 109
1:8 dil 123 84 48 108 98 91 94 63 87 105 70 110 66
Data Sheet - 77237
Biophys. Res. Comm., 77, 665-670 (1977).
Basophils
Kepley, C. et al., J. Immunol. Meth., 175, 1-9 (1994).
Arock, M. et al., Int. Arch. Allergy Immunol., 102, 107- 111 (1993).
Product Information Sheet -T2859
Drugs 27, 451,
(1989) (review).
37. Duax, W.L. et al. Environmental Health
Perspectives, 61, 111, (1985).
Notice
We provide information and advice to our customers
on application technologies
Product Information Sheet -
Biophys. Res.
Comm., 77, 665-670 (1977).
Basophils
Kepley, C. et al., J. Immunol. Meth., 175, 1-
9 (1994).
Arock, M. et al., Int. Arch. Allergy Immunol.,
102, 107-111 (1993).
Tanimoto
Product Information Sheet - P1644
Biochem. Biophys. Res. Comm., 77,
665-670 (1977).
Basophils
Kepley, C. et al., J. Immunol. Meth., 175, 1-9 (1994).
Arock, M. et al., Int. Arch. Allergy Immunol., 102, 107-
111 (1993).
Tanimoto, Y. et al.
Product Information Sheet - P7828
Biochem. Biophys. Res. Comm., 77,
665-670 (1977).
Basophils
Kepley, C. et al., J. Immunol. Meth., 175, 1-9 (1994).
Arock, M. et al., Int. Arch. Allergy Immunol., 102, 107-
111 (1993).
Tanimoto, Y. et al.
Product Information Sheet - E0414
Biochem. Biophys. Res. Comm., 77,
665-670 (1977).
Basophils
Kepley, C. et al., J. Immunol. Meth., 175, 1-9 (1994).
Arock, M. et al., Int. Arch. Allergy Immunol., 102, 107-
111 (1993).
Tanimoto, Y. et al.
Product Information Sheet - P4937
Biochem. Biophys. Res. Comm., 77,
665-670 (1977).
Basophils
Kepley, C. et al., J. Immunol. Meth., 175, 1-9 (1994).
Arock, M. et al., Int. Arch. Allergy Immunol., 102, 107-
111 (1993).
Tanimoto, Y. et al.
Product Information Sheet - E4632
Commun.,
248(1), 75-77 (1998).
5. Nilius, B., et al., Pharmacological modulation of
monovalent cation currents through the epithelial
Ca2+ channel ECaC1. Br. J. Pharmacol., 134(3),
453-462 (2001).
Product Information - A6424
Neurosci Lett., 328(3),
285-288 (2002).
3. Ulens, C., and Tytgat, J., Redox state dependency
of HERGS631C channel pharmacology: relation to
C-type inactivation. FEBS Lett., 474(1), 111-115
(2000).
Examination of Non-Specifically Bound Proteins and Peptides Following Depletion of Twenty High Abundance Proteins from Human Plasma
Fragment)”
77 1 111 1 112 1 110 1 54 1
IPI00022463 Serotransferrin precursor 393 8 131 3 551 11 193 6 571 11 543 11 67 1 194 5 828 14 1051 19
IPI00022432 Transthyretin precursor
Data Sheet - I17003
lymphokine. Blood, 77, 1859-70
(1991).
2. Mosmann, T.R., and Coffman, R.L., Heterogeneity
of cytokine secretion patterns and functions of
helper T cells. Adv. Immunol., 46, 111-47 (1989).
3. Romagnani
Data Sheet - I4902
Cell, 77, 391-400 (1994).
5. Type I (///) interferon family, interferon family,
in Guidebook to Cytokines and Their Receptors,
Nicola, N., ed., Oxford Press (New York, NY:
1994), pp. 111-114.
Verfication summary-03-0202-00
4.5 8% 95%
27.78 3 242 6.6 3% 30.88 0.9 3% 111%
13.89 3 104 6.8 7% 12.88 0.9 7% 93%
6.94 3 65 4.3 7% 7.73 0.6
Verfication summary-03-0202-00
4.5 8% 95%
27.78 3 242 6.6 3% 30.88 0.9 3% 111%
13.89 3 104 6.8 7% 12.88 0.9 7% 93%
6.94 3 65 4.3 7% 7.73 0.6
Proteoglycans
Rauterberg J. and Kresse H., JBC, 270, 2776-2783, (1995).
77. Pogany G., Hernandez D.J., and Vogel K.G., Arch.
Biochem. Biophys., 313, 102-111, (1994).
78. Roughley P.J., Melching L.I. and Recklies A.D
Proteoglycans (A1960)
Rauterberg J. and Kresse H., JBC, 270, 2776-2783, (1995).
77. Pogany G., Hernandez D.J., and Vogel K.G., Arch.
Biochem. Biophys., 313, 102-111, (1994).
78. Roughley P.J., Melching L.I. and Recklies A.D
Data Sheet - A1410
1. Merck Index, 12th ed., No. 2867 (1996).
2. Meienhofer, J., J. Am. Chem. Soc., 92, 3771-77
(1970).
3. Kleeff, J., et al.; Actinomycin D induces apoptosis
and inhibits growth of pancreatic cancer
Data Sheet - A4262
1. Merck Index, 12th ed., No. 2867 (1996).
2. Meienhofer, J., J. Am. Chem. Soc., 92, 3771-77
(1970).
3. Kleeff, J., et al.; Actinomycin D induces apoptosis
and inhibits growth of pancreatic cancer
Actinomycin D (A9415)
1. Merck Index, 12th ed., No. 2867 (1996).
2. Meienhofer, J., J. Am. Chem. Soc., 92, 3771-77
(1970).
3. Kleeff, J., et al.; Actinomycin D induces apoptosis
and inhibits growth of pancreatic cancer
Data Sheet - A5156
1. Merck Index, 12th ed., No. 2867 (1996).
2. Meienhofer, J., J. Am. Chem. Soc., 92, 3771-77
(1970).
3. Kleeff, J., et al.; Actinomycin D induces apoptosis
and inhibits growth of pancreatic cancer
Data Sheet - C0874 - Lot SLBB1500
References
1. Hoch, B. et al., Circ. Res., 84, 713-721 (1999).
2. Zhu, W.-Z. et al., J. Clin. Invest., 111, 617-625
(2003).
PRECISIO is a registered trademark of Sigma-Aldrich
Co. LLC.
TD,MAM 11/
Data Sheet - C0874
References
1. Hoch, B. et al., Circ. Res., 84, 713-721 (1999).
2. Zhu, W.-Z. et al., J. Clin. Invest., 111, 617-625
(2003).
PRECISIO is a registered trademark of Sigma-Aldrich
Co. LLC.
AD,TD,MAM
CAMK2 delta Active (C0874)
References
1. Hoch, B. et al., Circ. Res., 84, 713-721 (1999).
2. Zhu, W.-Z. et al., J. Clin. Invest., 111, 617-625
(2003).
Precisio is a registered trademark of Sigma-Aldrich
Biotechnology LP and Sigma-Aldrich
Data Sheet - C0874 - Lot 061M0737
References
1. Hoch, B. et al., Circ. Res., 84, 713-721 (1999).
2. Zhu, W.-Z. et al., J. Clin. Invest., 111, 617-625
(2003).
PRECISIO is a registered trademark of Sigma-Aldrich
Biotechnology LP and Sigma-Aldrich
CAMK2 delta Active (C0874)
References
1. Hoch, B. et al., Circ. Res., 84, 713-721 (1999).
2. Zhu, W.-Z. et al., J. Clin. Invest., 111, 617-625
(2003).
Precisio is a trademark of Sigma-Aldrich
Biotechnology LP and Sigma-Aldrich
GR 144053- Non-peptide antagonist of the platelet glycoprotein IIb/IIIa (GP IIb/IIIa) fibrinogen receptor
463-472 (1998).
75. Ratcliffe, C.F., et al., Nat. Neurosci., 3, 437-444 (2000).
76. Fujikawa, A., et al., Nat. Genet., 33, 375-381 (2003).
77. Yahiro, K., et al., J. Biol. Chem., 278, 19183-19189 (2003)
Quality Control Ranges: Milliplex Human Cytokine / Chemokine Immunoassay
1063 pg/mL Control 2 497– 1033 pg/mL
IL-9 Control 1 105 – 218 pg/mL MCP-1 Control 1 111– 230 pg/mL
Control 2 511
Page 1 of 6